Global Rheumatoid Arthritis Testing Market Insights, Forecast to 2028

Global Rheumatoid Arthritis Testing Market Insights, Forecast to 2028

Market Analysis and Insights: Global Rheumatoid Arthritis Testing Market
The global Rheumatoid Arthritis Testing market size is projected to reach US$ 34.86 billion by 2028, from US$ 23.18 billion in 2021, at a CAGR of 7.04% during 2022-2028.
Fully considering the economic change by this health crisis, Serological Tests accounting for 50.48% of the Rheumatoid Arthritis Testing global market in 2021, is projected to value US$ 1,663.85 million by 2028, growing at a revised 6.18% CAGR 2022-2028. While Hospitals and Clinics segment is altered to an 5.95% CAGR throughout this forecast period.
North America Rheumatoid Arthritis Testing market size is valued at US$ 817.03 million in 2021, while Europe and Asia Pacific Rheumatoid Arthritis Testing are US$ 574.49 million and US$ 534.39 million, severally. The proportion of the North America is 40.68% in 2021, while Europe and APAC are 28.60% and 26.61% respectively, and it is predicted that APAC proportion will reach 29.69% in 2028, trailing a CAGR of 8.66% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia. As for the Europe Rheumatoid Arthritis Testing landscape, Germany is projected to reach US$ 222.84 million by 2028 trailing a CAGR of 6.21% from 2022 to 2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatoid Arthritis Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatoid Arthritis Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatoid Arthritis Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatoid Arthritis Testing market.
Global Rheumatoid Arthritis Testing Scope and Market Size
Rheumatoid Arthritis Testing market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield

Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Ultrasound Diagnosis
Others

Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others

By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Egypt
Rest of MEA